Rewalk Robotics Ltd (RWLK) reported quarterly earnings results on Thursday, May-5-2016. The company said it had a profit of $-0.48 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.12. Analysts had a consensus of $-0.60. The company posted revenue of $2.06 million in the period, compared to analysts expectations of $1.61 million. The company’s revenue was up 224.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.48 EPS.
Rewalk Robotics Ltd opened for trading at $9.36 and hit $9.75 on the upside on Wednesday, eventually ending the session at $9.38, with a gain of 0.11% or 0.01 points. The heightened volatility saw the trading volume jump to 90,728 shares. Company has a market cap of $116 M.
Rewalk Robotics Ltd is an Israel-based medical device company. The Company is engaged in designing developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company has developed and is continuing to commercialize ReWalk an exoskeleton that uses its patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. The Company offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk is a product that can fundamentally change the health and life experiences of users. ReWalk controls movement using subtle changes in the users center of gravity.